Metamizole Sodium

CAS number： 68-89-3

Molecular formula： C13H16N3NaO4S

molecular weight： 333.34

Chemical structure：

Producers shown on SFDA

(Record date:20/10/2021）

Producer	Documents	GMP Valid till(based on SFDA)
Jiangsu Renhang Pharmaceutical Co., Ltd.	GMP	Valid till October 2024
Shandong Xinhua Pharmaceutical Co., Ltd.	GMP	Valid till March 2023
Baoji Tianxin Pharmaceutical Co., Ltd.	GMP	Valid till January 2023

Producers shown on EP

(Quoted from EP website；record date:20/10/2021）

Substance	Certificate Holder	Certificate Number	Issue Date	Status	End date	Type
Metamizole sodium monohydrate	VANI PHARMA LABS LIMITED Hyderabad IN	R1-CEP 2001-220 - Rev 01	08/09/2008	Withdrawn by EDQM Failure to CEP procedure	26/02/2010	Chemical
Metamizole sodium monohydrate	SANOFI-AVENTIS DEUTSCHLAND GMBH Frankfurt am Main DE	R1-CEP 2000-277 - Rev 05	14/06/2012	Valid	/	Chemical
Metamizole sodium monohydrate	WUHAN WUYAO PHARMACEUTICAL CO., LTD. Wuhan CN	R0-CEP 2014-091 - Rev 00	06/01/2017	Valid	/	Chemical
Metamizole sodium monohydrate	SHANDONG XINHUA PHARMACEUTICAL CO., LTD. Zibo CN	R1-CEP 2001-356 - Rev 04	11/08/2017	Valid	/	Chemical
Metamizole sodium monohydrate	HEBEI JIHENG PHARMACEUTICAL CO., LTD. Hengshui City CN	R1-CEP 2005-143 - Rev 02	03/03/2021	Valid	/	Chemical
Metamizole sodium monohydrate	ZHEJIANG HAISEN PHARMACEUTICAL CO., LTD. Xiangtan Village CN	R1-CEP 2004-016 - Rev 03	28/07/2021	Valid	/	Chemical

Producer:Jiangsu Renhang Pharmaceutical Co., Ltd., established in 2013, is a private enterprise producing chemical synthetic APIs, covering an area of 64000 square meters.
Staff size:About 50 persons

Registered capital:RMB 20 million

Producer:Shandong Xinhua Pharmaceutical Co., Ltd., established in Jiaodong Anti Japanese base in 1943, is the first chemical synthetic pharmaceutical enterprise in China, an important global production and export base of antipyretic and analgesic drugs, and an important domestic manufacturer of cardio cerebrovascular, anti infection and central nervous system. It has three pillar industries of chemical raw materials, pharmaceutical preparations and pharmaceutical intermediates, five industrial parks and 13 subsidiaries. The annual production capacity of chemical APIs is 40000 tons, pharmaceutical intermediates is 500000 tons, solid preparations are 28 billion tablets (tablets), and injections are 1 billion.

At present, all the drugs in production of Xinhua Pharmaceutical have passed the new national GMP certification, 18 products have passed the FDA inspection, 10 products have obtained the EU cos certificate, and the tablets have passed the MHRA audit of the UK drug and health products administration. More than 3 billion tablets have been exported to the EU high-end market, It has become one of the first 15 leading enterprises implementing the internationalization strategy of preparations in China and one of the top ten enterprises in the export of preparations in China.

Staff size:About 7000 persons

Registered capital:RMB 627 million 400 thousand

Producer:Baoji Tianxin Pharmaceutical Co., Ltd. is located in caijiapo economic and Technological Development Zone, Qishan County, Baoji City, Shaanxi Province. It is now renamed Shaanxi Baoxin Pharmaceutical Co., Ltd

The company is a pharmaceutical enterprise with many years of production experience and specializing in the production of chemical APIs and pharmaceutical intermediates. It has modern pharmaceutical equipment, advanced production technology, production workshops built in accordance with high GMP standards, strict management system and first-class control and testing means.

The main business is the production and sales of raw materials, mefenamic acid, and metamizole, and a series of pharmaceutical intermediates. More than 90% of the products are exported abroad.

Staff size:100-199 persons

Registered capital:RMB 3 million

For supply and market information, please feel free to contact Mr. Paul, paulzhang@yinuopharmchem.com, WhatsApp: +86 18402846978

Metamizole Sodium

Contact